Author:
Balamane Maya,Kolakowsky-Hayner Stephanie A.
Publisher
Springer International Publishing
Reference9 articles.
1. Abu-Kishk, I., Toledano, M., Reis, A., Daniel, D., & Berkovitch, M. (2004). Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic. Journal of Toxicology - Clinical Toxicology, 42(6), 921–925.
2. Joshi, P., Capozzoli, J., & Coyle, J. (1991). Neuroleptic malignant syndrome: Life-threatening complication of neuroleptic treatment in adolescents with affective disorder. Pediatrics, 87(2), 235.
3. Kaufman, K., Levitt, M., Schiltz, J., & Sunderram, J. (2006). Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: Case analysis. Annals of Clinical Psychiatry, 18(3), 201–204.
4. Morris, E., Green, D., & Graudins, A. (2009). Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine. Journal of Medical Toxicology, 5(1), 27–31.
5. Murray, J. (1987). Neuroleptic malignant syndrome. Journal of General Psychology, 114(1), 39.